Exact Mass: 471.2263768000001
Exact Mass Matches: 471.2263768000001
Found 68 metabolites which its exact mass value is equals to given mass value 471.2263768000001
,
within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error
0.0002 dalton.
5'-Guanidinonaltrindole
Zanubrutinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163774 - BTK-targeting Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents D006401 - Hematologic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(13R)-6alpha,7beta-dihydroxy-8beta,13-epoxy-11beta-nicotinyloxy-ent-clerodan-3-en-15,16-olide|scutelinquanine D
C26H33NO7 (471.22569080000005)
Cys Pro Pro Arg
C19H33N7O5S (471.2263768000001)
Cys Pro Arg Pro
C19H33N7O5S (471.2263768000001)
Cys Arg Pro Pro
C19H33N7O5S (471.2263768000001)
Gly His Lys Met
C19H33N7O5S (471.2263768000001)
Gly His Met Lys
C19H33N7O5S (471.2263768000001)
Gly Lys His Met
C19H33N7O5S (471.2263768000001)
Gly Lys Met His
C19H33N7O5S (471.2263768000001)
Gly Met His Lys
C19H33N7O5S (471.2263768000001)
Gly Met Lys His
C19H33N7O5S (471.2263768000001)
His Gly Lys Met
C19H33N7O5S (471.2263768000001)
His Gly Met Lys
C19H33N7O5S (471.2263768000001)
His Lys Gly Met
C19H33N7O5S (471.2263768000001)
His Lys Met Gly
C19H33N7O5S (471.2263768000001)
His Met Gly Lys
C19H33N7O5S (471.2263768000001)
His Met Lys Gly
C19H33N7O5S (471.2263768000001)
Lys Gly His Met
C19H33N7O5S (471.2263768000001)
Lys Gly Met His
C19H33N7O5S (471.2263768000001)
Lys His Gly Met
C19H33N7O5S (471.2263768000001)
Lys His Met Gly
C19H33N7O5S (471.2263768000001)
Lys Met Gly His
C19H33N7O5S (471.2263768000001)
Lys Met His Gly
C19H33N7O5S (471.2263768000001)
Met Gly His Lys
C19H33N7O5S (471.2263768000001)
Met Gly Lys His
C19H33N7O5S (471.2263768000001)
Met His Gly Lys
C19H33N7O5S (471.2263768000001)
Met His Lys Gly
C19H33N7O5S (471.2263768000001)
Met Lys Gly His
C19H33N7O5S (471.2263768000001)
Met Lys His Gly
C19H33N7O5S (471.2263768000001)
Pro Cys Pro Arg
C19H33N7O5S (471.2263768000001)
Pro Cys Arg Pro
C19H33N7O5S (471.2263768000001)
Pro Pro Cys Arg
C19H33N7O5S (471.2263768000001)
Pro Pro Arg Cys
C19H33N7O5S (471.2263768000001)
Pro Arg Cys Pro
C19H33N7O5S (471.2263768000001)
Pro Arg Pro Cys
C19H33N7O5S (471.2263768000001)
Arg Cys Pro Pro
C19H33N7O5S (471.2263768000001)
Arg Pro Cys Pro
C19H33N7O5S (471.2263768000001)
Arg Pro Pro Cys
C19H33N7O5S (471.2263768000001)
Zanubrutinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163774 - BTK-targeting Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents D006401 - Hematologic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Ansaetherone
C26H33NO7 (471.22569080000005)
An eleven-membered macrocyclic lactam that consists of (2S,3E,5Z,14S,15R)-5-ethylidene-11,14-dihydroxy-3,7,15-trimethyl-2,5-dihydro-2,13-ethano-1,9-benzoxazacycloundecine-6,8-dione in which the 14-hydroxy group is substituted by a (2R,5R,6R)-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl moiety. It is a radical scavenger isolated from Streptomyces.
Scutebarbatine G
C26H33NO7 (471.22569080000005)
A diterpene alkaloid of group of neo-clerodanes isolated from the whole plants of Scutellaria barbata and has been shown to exhibit neoplastic activity.
2-(4-{1-hydroxy-6,8,10-trimethyl-6h,6ah,7h,8h,9h,10h,10ah-isochromeno[4,3-c]pyridin-4-yl}phenoxy)-5-(hydroxymethyl)oxolane-3,4-diol
C26H33NO7 (471.22569080000005)
(6z,7z,9s,10r,11s)-6-ethylidene-3,14-dihydroxy-11-[(5-hydroxy-6-methyloxan-2-yl)oxy]-4,8,10-trimethyl-17-oxa-2-azatricyclo[7.6.2.0¹²,¹⁶]heptadeca-1(16),2,7,12,14-pentaen-5-one
C26H33NO7 (471.22569080000005)
1-ethyl-3a,6-dimethyl-3-oxo-4,5-dihydroazulen-4-yl 1-[2-(6-hydroxy-4-oxooxan-3-yl)acetyl]pyrrolidine-2-carboxylate
C26H33NO7 (471.22569080000005)
(7e,9s,10r,11s)-6-ethylidene-3,14-dihydroxy-11-{[(2r,5r)-5-hydroxy-6-methyloxan-2-yl]oxy}-4,8,10-trimethyl-17-oxa-2-azatricyclo[7.6.2.0¹²,¹⁶]heptadeca-1(16),2,7,12,14-pentaen-5-one
C26H33NO7 (471.22569080000005)
(6s,9s,10r,11s,16s)-6-ethyl-5,16-dihydroxy-11-{[(2r,5r,6r)-5-hydroxy-6-methyloxan-2-yl]oxy}-4,8,10-trimethyl-2-azatetracyclo[7.6.1.0²,⁶.0¹²,¹⁶]hexadeca-1(15),4,7,12-tetraene-3,14-dione
C26H33NO7 (471.22569080000005)
(2s,3r,4s,5r)-2-{4-[(6s,6ar,8r,10s,10ar)-1-hydroxy-6,8,10-trimethyl-6h,6ah,7h,8h,9h,10h,10ah-isochromeno[4,3-c]pyridin-4-yl]phenoxy}-5-(hydroxymethyl)oxolane-3,4-diol
C26H33NO7 (471.22569080000005)
(1s,5r,9r,11s,16s,17r,18s)-3,10-bis(acetyloxy)-9-hydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-19-yl acetate
C26H33NO7 (471.22569080000005)
6-ethylidene-3,14-dihydroxy-11-[(5-hydroxy-6-methyloxan-2-yl)oxy]-4,8,10-trimethyl-17-oxa-2-azatricyclo[7.6.2.0¹²,¹⁶]heptadeca-1(16),2,7,12,14-pentaen-5-one
C26H33NO7 (471.22569080000005)
methyl 7-(2-hydroxyethyl)-6,9a-dimethyl-3-(2-methyloctanoyl)-2,9-dioxofuro[3,2-g]isoquinoline-4-carboxylate
C26H33NO7 (471.22569080000005)
3,10-bis(acetyloxy)-9-hydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-19-yl acetate
C26H33NO7 (471.22569080000005)
(3ar,4s)-1-ethyl-3a,6-dimethyl-3-oxo-4,5-dihydroazulen-4-yl 1-[2-(6-hydroxy-4-oxooxan-3-yl)acetyl]pyrrolidine-2-carboxylate
C26H33NO7 (471.22569080000005)
1-ethyl-14,16-dihydroxy-6-[(5-hydroxy-6-methyloxan-2-yl)oxy]-3,5,15-trimethyl-17-oxa-13-azatetracyclo[9.5.1.0⁴,¹².0⁷,¹²]heptadeca-2,7,10,13,15-pentaen-9-one
C26H33NO7 (471.22569080000005)
methyl (9ar)-7-(2-hydroxyethyl)-6,9a-dimethyl-3-[(2r)-2-methyloctanoyl]-2,9-dioxofuro[3,2-g]isoquinoline-4-carboxylate
C26H33NO7 (471.22569080000005)
5,6-dihydroxy-4a,6a,7,10b-tetramethyl-5'-oxo-2,5,6,9,10,10a-hexahydro-1h-spiro[naphtho[2,1-b]pyran-3,3'-oxolan]-1-yl pyridine-3-carboxylate
C26H33NO7 (471.22569080000005)
(1s,3s,5r,8s,9r,10s,11r,14r,16s,17r,18s,19s)-3,10-bis(acetyloxy)-9-hydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-19-yl acetate
C26H33NO7 (471.22569080000005)
(4s,5s,6s,15e)-1-ethyl-14,16-dihydroxy-6-{[(2r,5r,6r)-5-hydroxy-6-methyloxan-2-yl]oxy}-3,5,15-trimethyl-17-oxa-13-azatetracyclo[9.5.1.0⁴,¹².0⁷,¹²]heptadeca-2,7,10,13,15-pentaen-9-one
C26H33NO7 (471.22569080000005)
(1s,3r,4ar,5s,6r,6ar,10as,10bs)-5,6-dihydroxy-4a,6a,7,10b-tetramethyl-5'-oxo-2,5,6,9,10,10a-hexahydro-1h-spiro[naphtho[2,1-b]pyran-3,3'-oxolan]-1-yl pyridine-3-carboxylate
C26H33NO7 (471.22569080000005)